The company
Arcus Biosciences, Inc.
RCUS · NYSE
RCUS stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 8.2% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $17.7M
- Officials’ trades on record
- 2
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
2 disclosed lines: House 0, Senate 0, executive 2; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Alexander AzoyChief Accounting Officer | sold | 2,827at $30.00 | 21 Aug 2026filed 24 Aug 2026 |
| Juan C. JaenPresident | sold | 19,799at $28.61 | 10 Jul 2026filed 13 Jul 2026 |
| Juan C. JaenPresident | sold | 268at $29.40 | 10 Jul 2026filed 13 Jul 2026 |
| Juan C. JaenPresident | sold | 48,502at $30.05 | 9 Jul 2026filed 13 Jul 2026 |
| Juan C. JaenPresident | sold | 6,431at $29.66 | 24 Jun 2026filed 24 Jun 2026 |
| Juan C. JaenPresident | sold | 14,067at $27.69 | 23 Jun 2026filed 24 Jun 2026 |
| Juan C. JaenPresident | sold | 1,697at $28.06 | 23 Jun 2026filed 24 Jun 2026 |
| Juan C. JaenPresident | sold | 9,236at $27.03 | 22 Jun 2026filed 24 Jun 2026 |
| Alexander AzoyChief Accounting Officer | sold | 2,562at $25.77 | 1 Jun 2026filed 1 Jun 2026 |
| Robert C. Goeltz IIChief Financial Officer | sold | 7,763at $25.63 | 11 May 2026filed 12 May 2026 |
| Juan C. JaenPresident | sold | 29,670at $21.34 | 5 Jan 2026filed 7 Jan 2026 |
| Juan C. JaenPresident | sold | 2,053at $22.34 | 5 Jan 2026filed 7 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.